ASH1L expression was significantly higher in tumors than adjacent nontumor tissues in our in‐house HCC cohort (cohort 1, 99 pairs), consistent with results observed from TCGA (Figure 8A; Figure S9A, Supporting Information). Here, ASH1L is linked to hepatocellular carcinoma.